Akebia Therapeutics

165 articles with Akebia Therapeutics

• Akebia To Present At The Cantor Fitzgerald Annual Healthcare Conference

  7/6/2016

• Akebia Announces Positive Vadadustat Data Demonstrating No Clinically Significant Drug-Drug Interaction

  5/23/2016

• Akebia To Present At The 2016 UBS Global Healthcare Conference

  5/16/2016

• Akebia Announces First Quarter 2016 Financial Results And Provides Corporate Update

  5/6/2016

• Akebia Announces Presentation Of Vadadustat Phase 2 Dialysis Data At Upcoming National Kidney Foundation 2016 Spring Clinical Meetings

  4/26/2016

• Akebia To Present At The 15th Annual Needham Healthcare Conference

  4/5/2016

• Akebia Announces Fourth Quarter And Full-Year 2015 Financial Results

  3/15/2016

• Akebia To Host Conference Call On March 14th To Discuss Full-Year 2015 Financial Results And Corporate Highlights

  3/9/2016

• Akebia Prevails In European Patent Dispute And Preserves Access To Key Market For Vadadustat

  3/9/2016

• Akebia To Present At The 18th Annual BIO CEO & Investor Conference

  2/1/2016

• Akebia Prices Public Offering Of Common Stock

  1/7/2016

• Akebia Initiates Phase 3 PRO2TECT Program

  1/5/2016

• Akebia Announces Proposed Public Offering Of Common Stock

  1/5/2016

• Cambridge's Akebia Grabs an Asian Partner and Funding for Anemia Pill in $350 Million Deal

  12/14/2015

• Akebia And Mitsubishi Tanabe Announce Collaboration To Develop And Commercialize Vadadustat In Asia

  12/14/2015

• Akebia Therapeutics, Inc. Announces Third Quarter 2015 Financial Results

  11/9/2015

• Akebia Therapeutics, Inc. Announces Presentation of Vadadustat Phase II Dialysis Data at American Society of Nephrology Kidney Week 2015 Annual Meeting

  11/9/2015

• Akebia To Present At The Credit Suisse 24th Annual Healthcare Conference

  11/4/2015

• Akebia Therapeutics, Inc. Announces Presentations At The Upcoming American Society Of Nephrology Kidney Week 2015 Annual Meeting

  10/29/2015

• Akebia Therapeutics, Inc. Reaches Agreement With FDA And European Medicines Agency On Vadadustat Global Phase III Program

  10/6/2015